| Literature DB >> 31727271 |
Abstract
Chick chorioallantoic membrane (CAM) assay provides a convenient and versatile model for the study of tumor formation, angiogenesis and metastasis. While the assay has been used for more than 100 years, the CAM assay has recently received renewed interest. One of the recent interests comes from the development of Precision Medicine in cancer therapy. The idea is to develop treatments that are tailor-made for each individual patient. For this to happen, patient-derived tumor models are critical and the CAM assay can make significant contribution. The other development concerns various applications of the CAM assay. Using this assay, various reagents have been identified. This includes sensitizers for radiation therapy and photodynamic therapy. We also discuss boron neutron capture therapy (BNCT) that is based on the splitting of boron-10 upon exposure to neutron beam. Recently, various boron-10 reagents have been developed and they can be examined for their efficacy for BNCT therapy using the CAM assay.Entities:
Keywords: Applications; Boron neutron capture therapy; CAM assay; Mechanism of tumor formation; Number of publications; Patient-derived models; Precision medicine
Mesh:
Year: 2019 PMID: 31727271 DOI: 10.1016/bs.enz.2019.10.002
Source DB: PubMed Journal: Enzymes ISSN: 1874-6047